Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17973541 | 0.82 | CAPN1 (0.31) | — | |
| SCHEMBL17973548 | 0.79 | — | — | |
| SCHEMBL14338195 | 0.78 | MME (0.42) | MMEALDH1A1THRBCYP2C9CYP2C19 | |
| SCHEMBL12903772 | 0.78 | MME (0.42) | MMEALDH1A1THRBCYP2C9CYP2C19 | |
| SCHEMBL13380097 | 0.77 | MME (0.53) | MMEALDH1A1THRBCYP2C9CYP2C19 | |
| SCHEMBL7327700 | 0.77 | MME (0.53) | MMEALDH1A1THRBCYP2C9CYP2C19 | |
| SCHEMBL7032142 | 0.75 | MME (0.36) | MMEALDH1A1THRBCYP2C9CYP2C19 | |
| SCHEMBL108288 | 0.74 | NPC1 (0.31) | — | |
| SCHEMBL17973550 | 0.74 | ALDH1A1 (0.38) | ALDH1A1THRBCYP2C9CYP2C19HSD17B10 | |
| SCHEMBL17973552 | 0.74 | MME (0.48) | MME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160222430-A1 | D-ALA-D-ALA-BASED DIPEPTIDES AS TOOLS FOR IMAGING PEPTIDOGLYCAN BIOSYNTHESIS | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION | 2016-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160222430-A1 | D-ALA-D-ALA-BASED DIPEPTIDES AS TOOLS FOR IMAGING PEPTIDOGLYCAN BIOSYNTHESIS | DNPEP, DDOST, ALAD | MME 679/4885ALDH1A1 4149/4885THRB 773/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.